LOGIN  |  REGISTER
Assertio

BUY $ASRT

Buy $ASRT on Charles Schwab

Buy $ASRT on ETrade

Buy $ASRT on Public.com

Buy $ASRT on Fidelity

Buy $ASRT on  Robinhood

Buy $ASRT on Webull

Assertio to Participate in the HC Wainwright and Lake Street Conferences in September 2025

September 03, 2025 | Last Trade: US$0.81 0.01 1.63

LAKE FOREST, Ill., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) announced that members of its management team will host investor meetings at two investor conferences in New York City during September 2025.

Company management will host investor meetings at the HC Wainwright Conference on Wednesday, September 10, 2025, taking place at the Lotte New York Palace Hotel. Investors can register and request meetings via their HC Wainwright representative.

The Company will also participate in investor meetings at the Lake Street Capital Markets BIG9 Conference, taking place September 11, 2025 at the Yale Club New York City. Investors can register and request meetings through their Lake Street representative.

About Assertio

Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs. Our focus is on supporting patients by marketing products in oncology, neurology, and pain management. To learn more about Assertio, visit www.assertiotx.com.

Investor Contact

Matt Kreps, Managing Director
Darrow Associates
M: 214-597-8200
This email address is being protected from spambots. You need JavaScript enabled to view it.

BUY $ASRT

Buy $ASRT on Charles Schwab

Buy $ASRT on ETrade

Buy $ASRT on Public.com

Buy $ASRT on Fidelity

Buy $ASRT on  Robinhood

Buy $ASRT on Webull

Stock Quote

BUY $ASRT

Buy $ASRT on Charles Schwab

Buy $ASRT on ETrade

Buy $ASRT on Public.com

Buy $ASRT on Fidelity

Buy $ASRT on  Robinhood

Buy $ASRT on Webull

Assertio

Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through...

CLICK TO LEARN MORE
Assertio

Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital, and pain and inflammation. Assertio has grown through...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page